Cargando…

ERBB3 is required for metastasis formation of melanoma cells

Melanoma is curable when it is at an early phase but is lethal once it becomes metastatic. The recent development of BRAF(V600E) inhibitors (BIs) showed great promise in treating metastatic melanoma, but resistance developed quickly in the treated patients, and these inhibitors are not effective on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tiwary, S, Preziosi, M, Rothberg, P G, Zeitouni, N, Corson, N, Xu, L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150209/ https://www.ncbi.nlm.nih.gov/pubmed/25000258 http://dx.doi.org/10.1038/oncsis.2014.23

Ejemplares similares

FRIZZLED7 Is Required for Tumor Inititation and Metastatic Growth of Melanoma Cells
por: Tiwary, Shweta, et al.
Publicado: (2016)

Correction: FRIZZLED7 Is Required for Tumor Inititation and Metastatic Growth of Melanoma Cells
por: Tiwary, Shweta, et al.
Publicado: (2017)

Cardiac Melanoma Metastasis with ERBB2 Gene Amplification: A Potential for Future Targeted Therapy
por: Gams, Polona, et al.
Publicado: (2021)

APIP, an ERBB3-binding partner, stimulates erbB2-3 heterodimer formation to promote tumorigenesis
por: Hong, Se-Hoon, et al.
Publicado: (2016)

Synchronized targeting of Notch and ERBB signaling suppresses melanoma tumor growth through inhibition of Notch1 and ERBB3
por: Zhang, Keman, et al.
Publicado: (2015)

ErbB3 is required for ductal morphogenesis in the mouse mammary gland
por: Jackson-Fisher, Amy J, et al.
Publicado: (2008)

ERBB1/2/3 Expression, Prognosis, and Immune Infiltration in Cutaneous Melanoma
por: Liu, Shougang, et al.
Publicado: (2021)

Blocking c-MET/ERBB1 Axis Prevents Brain Metastasis in ERBB2+ Breast Cancer
por: Gautam, Shailendra K., et al.
Publicado: (2020)

ARAF suppresses ERBB3 expression and metastasis in a subset of lung cancers
por: Mooz, Juliane, et al.
Publicado: (2022)

MITF depletion elevates expression levels of ERBB3 receptor and its cognate ligand NRG1-beta in melanoma
por: Alver, Tine N., et al.
Publicado: (2016)

Quantitative Phosphoproteomics Analysis of ERBB3/ERBB4 Signaling
por: Wandinger, Sebastian K., et al.
Publicado: (2016)

Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence
por: Pandya, K, et al.
Publicado: (2011)

Continuous requirement of ErbB2 kinase activity for loss of cell polarity and lumen formation in a novel ErbB2/Neu-driven murine cell line model of metastatic breast cancer
por: Ortega-Cava, Cesar F., et al.
Publicado: (2011)

Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis
por: Smirnova, Tatiana, et al.
Publicado: (2011)

Loss of YY1, a Regulator of Metabolism in Melanoma, Drives Melanoma Cell Invasiveness and Metastasis Formation
por: Guendisch, Ulf, et al.
Publicado: (2022)

Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies
por: Fattore, Luigi, et al.
Publicado: (2013)

Erbb4 Is Required for Cerebellar Development and Malignant Phenotype of Medulloblastoma
por: Aldaregia, Juncal, et al.
Publicado: (2020)

The importance of microenvironment: the role of CCL8 in metastasis formation of melanoma
por: Barbai, Tamás, et al.
Publicado: (2015)

Both HDAC5 and HDAC6 are required for the proliferation and metastasis of melanoma cells
por: Liu, Jiaqi, et al.
Publicado: (2016)

ERBB3 (HER3) is a key sensor in the regulation of ERBB-mediated signaling in both low and high ERBB2 (HER2) expressing cancer cells
por: Choi, Byung-Kwon, et al.
Publicado: (2012)

Expression of the ERBB3 gene product in breast cancer.
por: Lemoine, N. R., et al.
Publicado: (1992)

Endocrine resistance in breast cancer: new roles for ErbB3 and ErbB4
por: Sutherland, Robert L
Publicado: (2011)

Activation of the ErbB3-AKT axis promotes melanoma cell survival and proliferation in response to RAF/MEK inhibition
por: Fattore, Luigi, et al.
Publicado: (2014)

Germline ERBB3 mutation in familial non-small-cell lung carcinoma: expanding ErbB’s role in oncogenesis
por: McInerney-Leo, Aideen M, et al.
Publicado: (2021)

miR-152 is involved in the proliferation and metastasis of ovarian cancer through repression of ERBB3
por: Li, Lian-Wei, et al.
Publicado: (2018)

Erbb2 Is Required for Cardiac Atrial Electrical Activity during Development
por: Tenin, Gennadiy, et al.
Publicado: (2014)

The absence of the ERBB4 hotspot mutations in melanomas in patients from southern China
por: Zhou, Qi-Ming, et al.
Publicado: (2013)

ErbB activation signatures as potential biomarkers for anti-ErbB3 treatment in HNSCC
por: Alvarado, Diego, et al.
Publicado: (2017)

Myosin X is required for efficient melanoblast migration and melanoma initiation and metastasis
por: Tokuo, Hiroshi, et al.
Publicado: (2018)

Multiple Functional Motifs Are Required for the Tumor Suppressor Activity of a Constitutively-Active ErbB4 Mutant
por: Gallo, Richard M., et al.
Publicado: (2013)

Fulvestrant-induced expression of erbB3 and erbB4 sensitizes ER-positive breast cancer cells to heregulins
por: Hutcheson, IR, et al.
Publicado: (2010)

Asymmetric kinase dimer formation is crucial for the activation of oncogenic EGFRvIII but not for ERBB3 phosphorylation
por: Kancha, Rama Krishna, et al.
Publicado: (2013)

The Adhesion G-Protein-Coupled Receptor, GPR56/ADGRG1, Inhibits Cell–Extracellular Matrix Signaling to Prevent Metastatic Melanoma Growth
por: Millar, Michelle W., et al.
Publicado: (2018)

Phosphatase of Regenerating Liver-3 Localizes to Cyto-Membrane and Is Required for B16F1 Melanoma Cell Metastasis In Vitro and In Vivo
por: Song, Ran, et al.
Publicado: (2009)

Effect of melanoma stem cells on melanoma metastasis
por: Yin, Qiliang, et al.
Publicado: (2021)

Epidermal growth factor–stimulated Akt phosphorylation requires clathrin or ErbB2 but not receptor endocytosis
por: Garay, Camilo, et al.
Publicado: (2015)

FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion
por: Benlimame, Naciba, et al.
Publicado: (2005)

MiR-200b Suppresses Gastric Cancer Cell Migration and Invasion by Inhibiting NRG1 through ERBB2/ERBB3 Signaling
por: Xu, Tonglei, et al.
Publicado: (2021)

Proliferation of Colorectal Cancer Is Promoted by Two Signaling Transduction Expression Patterns: ErbB2/ErbB3/AKT and MET/ErbB3/MAPK
por: Yao, Yong-Liang, et al.
Publicado: (2013)

Cdk5 Phosphorylation of ErbB4 is Required for Tangential Migration of Cortical Interneurons
por: Rakić, Sonja, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_aqvnf86hg6im6u6d44k6snpugq